| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 15.345 | 12.307 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 15.345 | 12.307 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 18 | 0 | 0 | 11.774 | 11.072 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -18 | 0 | 0 | 3.571 | 1.235 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -18 | 0 | 0 | 3.110 | 866 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rovitalexim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 831 | 823 | 809 | 5.547 | 343 | 337 | 329 | 330 | 329 | 327 |
| Inventories | 827 | 819 | 805 | 0 | 153 | 150 | 147 | 147 | 147 | 146 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 4 | 4 | 4 | 5.547 | 191 | 187 | 183 | 183 | 183 | 182 |
| Shareholders Funds | -13.809 | -13.668 | -13.437 | -10.080 | -9.019 | -8.848 | -8.652 | -8.678 | -8.652 | -8.604 |
| Social Capital | 675 | 668 | 657 | 645 | 632 | 620 | 606 | 608 | 606 | 603 |
| Debts | 14.640 | 14.491 | 14.246 | 15.627 | 9.362 | 9.185 | 8.981 | 9.009 | 8.982 | 8.931 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5540 - 5540" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Rovitalexim S.r.l.